Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cochlear

Founders Graeme Clark

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 3
Rounds per year 0.12
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Medical Device
  • Neuroscience
  • Biotechnology
Summary

Cochlear appeared to be the Corporate Investor, which was created in 1982. The main department of described Corporate Investor is located in the Sydney. The company was established in Australia.

The top activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 9-10 participants. Despite the Cochlear, startups are often financed by New Enterprise Associates, Lightstone Ventures, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, New Enterprise Associates. In the next rounds fund is usually obtained by CRG L.P., Windham Venture Partners, Vertex Ventures HC.

Among the most popular portfolio startups of the fund, we may highlight Earlens Corporation, Nyxoah. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cochlear:
Typical Co-investors
Cochlear is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cochlear:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China Merchants Financial Leasing China, Hong Kong, Hong Kong Island
Cofounders Capital Cary, North Carolina, United States
FastPay California, Los Angeles, United States
Genimous China, Henan, Zhengzhou
Gestora de Finances per Emprenedor Barcelona, Catalonia, Spain
Jettfrogg LLC -
Keadyn Rotterdam, The Netherlands, Zuid-Holland
Rockmore Capital New York, New York, United States
Sichuan E-commerce Industry Equity Investment Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Seer

Biotechnology
Health Care
Machine Learning
$24M27 Aug 2021 Melbourne, Victoria, Australia

Nyxoah

Health Care
Medical
Medical Device
Neuroscience
$17M12 Nov 2018 Walloon Brabant

Earlens Corporation

Health Care
Medical
Medical Device
$73M05 Jun 2017 California, United States

Earlens Corporation

Health Care
Medical
Medical Device
$34M16 Jun 2016 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cochlear?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 35M
Rounds per year 0.12
Peak activity year 2020
Lead investments 1
Follow on index 0.40
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Seer

Biotechnology
Health Care
Machine Learning
$24M27 Aug 2021 Melbourne, Victoria, Australia

Nyxoah

Health Care
Medical
Medical Device
Neuroscience
$17M12 Nov 2018 Walloon Brabant

Earlens Corporation

Health Care
Medical
Medical Device
$73M05 Jun 2017 California, United States

Earlens Corporation

Health Care
Medical
Medical Device
$34M16 Jun 2016 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: